GEN-MKT-18-7897-A
Jan 24, 2017 | Biopharma, Blogs | 0 comments
Have you ever wished for a compact instrument that delivers expert-level answers to your most complex biotherapeutic characterization challenges faster and easier than what you are doing now? At SCIEX, we recognize that even expert users want easier ways to perform daily characterization tasks and get great results every time. That’s why we set out to develop the X500B QTOF system: a robust and reliable new instrument and software solution that reduces complexity and simplifies biologics characterization workflows so every scientist can get expert-level results.Download Info Pack >
Flexible and Robust: The X500B QTOF Makes Standard Characterization Workflows a Breeze
The new X500B QTOF system is the first true benchtop, high-resolution mass spectrometer designed specifically for characterization of complex biologics, delivering high-quality data for intact mass and peptide mapping analyses–including post-translational modification identification–and characterization of antibody-drug conjugates. The system utilizes the renowned SCIEX Turbo V™ ionization source and a heated TOF path for maximum robustness and reproducibility. Add to that the new SCIEX OS Operating System and BioPharmaView™ data processing software, which are surprisingly easy to learn and operate.
The new X500B system enables you to:
As a part of the SCIEX 360º Innovation for Biologics Characterization strategy, the X500B QTOF system is designed to help you get better answers, faster. For standard biologics characterization workflows, the compact X500B system is the next “big” thing to improve your lab’s productivity and throughput.
Download your free information pack showing how simple it is to set up your biologics characterization, including:
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network